What is the significance of an omental cake located between the pancreas and kidney, and what diagnostic and therapeutic steps should be taken?

Omental Cake Between Pancreas and Kidney

An omental cake located between the pancreas and kidney most likely represents peritoneal carcinomatosis from pancreatic adenocarcinoma, indicating stage IV disease that is unresectable and requires systemic chemotherapy rather than surgical intervention.

Clinical Significance and Prognosis

The presence of omental cake in the context of pancreatic pathology represents intraperitoneal dissemination and constitutes metastatic disease 1. This finding indicates:

• Stage IV pancreatic cancer with peritoneal carcinomatosis, which carries a grave prognosis with >95% mortality 1
• The patient is not a surgical candidate for curative resection 1
• Life expectancy is typically measured in months rather than years 1

Diagnostic Workup

Imaging Confirmation

CT scan is the preferred initial imaging modality for diagnosis and staging 1. The CT should include:

• Multiphase thin-section images including pancreatic, arterial, and portal venous phases 1
• Assessment of the primary pancreatic tumor size and location 1
• Evaluation for hepatic metastases, lymphadenopathy, and peritoneal dissemination 1
• Documentation of vascular involvement of major vessels adjacent to the pancreas 1

MRI may be superior to CT for detecting small liver metastases, identifying occult metastases in 10-23% of cases that CT misses 1. Consider MRI if surgical resection is being contemplated despite the omental cake finding.

Tissue Diagnosis

Pathological confirmation is mandatory before initiating palliative chemotherapy 1. Options include:

• CT-guided or ultrasound-guided biopsy of the omental cake or other accessible metastatic sites 1
• EUS-guided fine needle biopsy of the pancreatic mass or accessible lymph nodes 1
• Laparoscopy with biopsy can detect small peritoneal and liver metastases, changing therapeutic strategy in <15% of patients 1

Avoid transperitoneal biopsy if there is any consideration of resection, though with omental cake present, the disease is already metastatic 1.

Tumor Markers and Molecular Testing

• CA19.9 baseline measurement for monitoring treatment response, though it lacks diagnostic specificity 1
• Germline testing should be performed in all patients with confirmed pancreatic cancer for hereditary cancer syndromes (BRCA1/2, PALB2, ATM) 1, 2
• Somatic mutation testing for actionable mutations including BRAF, BRCA1/2, HER2, KRAS, NTRK fusions, and MMR deficiency 1

Therapeutic Management

Systemic Chemotherapy

For patients with good performance status (ECOG 0-1), FOLFIRINOX is the preferred first-line regimen 1. This combination showed:

• Median progression-free survival of 6.4 months versus 3.3 months with gemcitabine (P<0.001) 1
• Dramatic improvements in overall survival 1

For patients with borderline performance status or older age, gemcitabine-based regimens are appropriate alternatives 1.

Palliative Interventions

Given the metastatic nature with omental involvement:

• Endoscopic biliary stenting if jaundice is present (70-80% of head lesions cause jaundice); metal stents preferred for life expectancy >3 months 1
• Pain management using progressive analgesic ladder with opioids; consider celiac plexus blockade with 50-90% response rates 1
• Pancreatic enzyme supplementation to maintain weight and quality of life 1
• Early palliative care referral 1

What NOT to Do

• Do not pursue surgical resection - omental cake represents peritoneal carcinomatosis and is a contraindication to curative surgery 1
• Do not perform prophylactic gastroenterostomy routinely, as only 13-15% will require it 1
• Avoid percutaneous biliary drainage prior to any potential resection as it increases infective complications, though resection is not indicated here 1

Differential Diagnosis Considerations

While pancreatic adenocarcinoma is most likely given the anatomic location, omental cake can rarely result from 3, 4, 5:

• Peritoneal mesothelioma (associated with asbestos exposure) 3
• Ovarian carcinoma (most common cause of omental cake overall, but less likely with pancreatic mass) 4
• Gastric or colonic adenocarcinoma 4, 5
• Lymphoma (both Hodgkin's and non-Hodgkin's, though rare) 5

Biopsy is essential when etiology is uncertain to direct appropriate management 4.

Imaging Features to Confirm Malignancy

On MRI, malignant omental caking demonstrates 6:

• Hyperintensity on high b-value diffusion-weighted imaging (88% sensitivity) 6
• Hyperenhancement (75% sensitivity) 6
• Convex outer omental contour (75-88% sensitivity) 6

These features help differentiate malignant from benign omental thickening (such as from portal hypertension) 6.